FREE Account Opening + No Clearing Fees
Loading...

Ameya Engineers IPO vs EP Biocomposites IPO

Comparision between Ameya Engineers IPO and EP Biocomposites IPO.

IPO Details

Ameya Engineers IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while EP Biocomposites IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  Ameya Engineers IPO EP Biocomposites IPO
Logo Ameya Engineers IPO Logo EP Biocomposites IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At NSE SME BSE SME
Lead Managers Shreni Shares Limited Aryaman Financial Services Limited
Registrar Skyline Financial Services Private Ltd Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Ameya Engineers IPO is up to ₹7.14 Cr whereas the issue size of the EP Biocomposites IPO is up to ₹6.35 Cr. The final issue price of Ameya Engineers IPO is ₹34.00 per share and of EP Biocomposites IPO is ₹126.00 per share.

  Ameya Engineers IPO EP Biocomposites IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹34.00 per share ₹126.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 4000 shares 1000 shares
Fresh Issue Size 15,00,000 shares 5,04,000 shares
Fresh Issue Size (Amount) up to ₹5.10 Cr up to ₹6.35 Cr
OFS Issue Size 6,00,000 shares
OFS Issue Size (Amount) up to ₹2.04 Cr
Issue Size Total 21,00,000 shares 5,04,000 shares
Issue Size Total (Amount) up to ₹7.14 Cr up to ₹6.35 Cr

IPO Timetable

Ameya Engineers IPO opens on Aug 25, 2022, while EP Biocomposites IPO opens on Aug 29, 2022. The closing date of Ameya Engineers IPO and EP Biocomposites IPO is Aug 30, 2022, and Sep 05, 2022, respectively.

  Ameya Engineers IPO EP Biocomposites IPO
Anchor Bid Date
Issue Open Aug 25, 2022 Aug 29, 2022
Issue Close Aug 30, 2022 Sep 05, 2022
Basis Of Allotment (Tentative) Sep 05, 2022 Sep 08, 2022
Initiation of Refunds (Tentative) Sep 06, 2022 Sep 09, 2022
Credit of Share (Tentative) Sep 07, 2022 Sep 12, 2022
Listing date (Tentative) Sep 08, 2022 Sep 13, 2022
Anchor Lockin End date 1 Oct 05, 2022 Oct 08, 2022
Anchor Lockin End date 2 Dec 04, 2022 Dec 07, 2022

Financials

Ameya Engineers IPO P/E ratio is 16.75, as compared to EP Biocomposites IPO P/E ratio of 26.2.

  Ameya Engineers IPO EP Biocomposites IPO
Financial
Ameya Precision Engineers Ltd Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Mar-202235.22347.76180.04925.9825.9
31-Mar-212011.82488.58272.641198.54998.54
31-Mar-221998.072396.36152.971350.51750.51
Amount in ₹ Lakhs
EP Biocomposites Limited Financial Information (Restated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Mar-2055.1656.833.152.85-2.15
31-Mar-21132.38295.2335.838.6533.65
31-Mar-22927.69807.5580.94199.8482.09
Amount in ₹ Lakhs
Promoter Shareholding (Pre-Issue) 99.99% 98.97%
Promoter Shareholding (Post-Issue) 71.9960% 69.40%
P/E Ratio 16.75 26.2
Market Cap ₹25.50 Cr. ₹21.19 Cr.
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Ameya Engineers IPO retail investors (RII) are offered 9,96,000 shares while in EP Biocomposites IPO retail investors are offered 9,96,000 shares. Qualified institutional buyers (QIB) are offered in Ameya Engineers IPO and in EP Biocomposites IPO.

  Ameya Engineers IPO EP Biocomposites IPO
Anchor Investor Reserveration
Market Maker Reserveration 1,08,000 shares 28,000 shares
QIB
NII 9,96,000 shares 2,38,000 shares
RII 9,96,000 shares 2,38,000 shares
Employee
Others
Total 19,92,000 shares 4,76,000 shares

Bids Received (Subscription)

Ameya Engineers IPO subscribed 251.35x in total, whereas EP Biocomposites IPO subscribed 18.51x.

  Ameya Engineers IPO EP Biocomposites IPO
QIB (times)
NII (times) 259.16x 21.58x
Big NII (times)
Small NII (times)
RII (times) 243.53x 15.44x
Employee (times)
Other (times)
Total (times) 251.35x 18.51x

Comments

Add a public comment...